Emu oil offers protection in Crohn’s disease model in rats

详细信息    查看全文

• 作者：Bhaskar Vemu ; S. Selvasubramanian…
• 关键词：Aloe vera ; Crohn’s disease ; Emu oil ; Indomethacin
• 刊名：BMC Complementary and Alternative Medicine
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：16
• 期：1
• 全文大小：1,548 KB
• 参考文献：1.Fiocchi C. Inflammatory Bowel Disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205.CrossRef PubMed
  2.Triantafillidis KJ, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Dev Ther. 2011;5:185–210.CrossRef
  3.Deshmukh CD, Pawar AT, Bantal V. Effect of Embilica officinalis methanolic fruit extract on indomethacin induced enterocolitis in rats. Res J Med Plant. 2010;4:141–8.CrossRef
  4.Krebs S, Omer TN, Omer B. Wormwood (Artemisia absinthium) suppresses tumor necrosis factor alpha and accelerates healing in patients with Crohn’s disease – A controlled clinical trial. Phytomedicine. 2010;17:305–9.CrossRef PubMed
  5.Jia Q, Ivanov I, Zlatev ZZ, Alaniz RC, Weeks BR, Callaway ES, et al. Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate treated mice. Br J Nutr. 2011;106:519–29.PubMedCentral CrossRef PubMed
  6.Neilson AP, Djuric Z, Ren J, Hong YH, Sen A, Lager C, et al. Effect of cyclooxygenase genotype and dietary fish oil on colonic eicosanoids in mice. J Nutr Biochem. 2012;23:966–76.PubMedCentral CrossRef PubMed
  7.Rahimi R, Ardekani MRS, Abdollahi M. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. World J Gastroenterol. 2010;16(36):4504–14.PubMedCentral CrossRef PubMed
  8.Park MY, Kwon HJ, Sung MK. Dietary aloin, aloesin, or aloe-gel exerts anti-inflammatory activity in a rat colitis model. Life Sci. 2011;88:486–92.CrossRef PubMed
  9.Whitehouse MW, Turner AG, Davis CKC, Roberts MS. Emu Oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine. Inflammopharmacology. 1998;6:1–7.CrossRef PubMed
  10.Vemu B, Selvasubramanian S, Pandiyan V. Anti-inflammatory activity of emu oil in indomethacin induced inflammatory bowel disease in rats. Proc Indian Natl Sci Acad B Biol Sci. 2015; doi: 10.​1007/​s40011-015-0564-3 .
  11.Khare S, Asad M, Dhamanigi SS, Satya PV. Antiulcer activity of cod liver oil in rats. Ind J Pharmacol. 2008;40(5):209–14.CrossRef
  12.Yoganathan S, Nicolosi R, Wilson T. Antagonism of croton oil inflammation by topical emu oil in CD-1 mice. Lipids. 2003;38:603–7.CrossRef PubMed
  13.Lagniel C, Torres AM. Consequences of burn injuries treatment with 100 % pure emu oil. Burns. 2007;33:S148.CrossRef
  14.Wilson AT, Nicolosi RJ, Handelman G, Yoganathan S, Kotyla T, Orthoefer F, et al. Comparative effects of emu and olive oil on aortic early atherosclerosis and associated risk factors in hypercholesterolemic hamsters. Nutr Res. 2004;24:395–406.CrossRef
  15.Abimosleh SM, Lindsay RJ, Butler RN, Cummins AG, Howarth GS. Emu oil increases colonic crypt depth in a rat model of ulcerative colitis. Dig Dis Sci. 2011;57:887–96.CrossRef PubMed
  16.Abimosleh SM, Tran CD, Howarth GS. Emu Oil: a novel therapeutic for disorders of the gastrointestinal tract? J Gastroenterol Hepatol. 2012;27:857–61.CrossRef PubMed
  17.Sartor RB. Insights into the pathogenesis of inflammatory bowel diseases provided by New Rodent Models of spontaneous colitis. Inflamm Bowel Dis. 1995;1:64–75.
  18.Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation. 1993;17:641–62.CrossRef PubMed
  19.Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. the inflammatory bowel disease study group. Similarities between ileal Crohn’s disease and indomethacin experimental jejunal ulcers in the rat. Aliment Pharmacol Therapeut. 2000;14:241–5.CrossRef
  20.Bonner GF, Fakhri A, Vennamaneni SR. A long term cohort study of non steroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:751–7.CrossRef PubMed
  21.Langmead L, Feakins RM, Goldthorpe S, Holt H, Tsironi E, De Silva A, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Therapeut. 2004b;19:739-47.
  22.Shirke SS. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases, M. Pharm. Thesis, Mumbai University, Mumbai, 2002. In: Jagtap AG, Niphadkar PV. Protective effect of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice. Indian J Exp Biol. 2011;49:343–51.
  23.Yagi K. Simple fluorimetric assay for lipid peroxides in blood plasma. Biochem Med. 1976;15:212–6.CrossRef PubMed
  24.Caliborne AL. Assay of catalase. In: Greenwald RA, editor. Handbook of Oxygen Radical Research. Florida: CRC Press; 1985. p. 196–201.
  25.Marklund SL, Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47:474–96.CrossRef
  26.Rotruck JD, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium, biochemical role as a component of glutathione peroxidase and assay. Science. 1973;179:588–90.CrossRef PubMed
  27.Meron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione-s-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979;582:67–78.CrossRef
  28.Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1986;87:1344–50.
  29.Ashtaral NL, Mohammadirad A, Yasa N, Minaie B, Nikfar S, Ghazanfari G, et al. Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease. eCAM. 2006;4:43–50.
  30.Kelfalakes H, Stylianides TJ, Amanakis G, Kolios G. Exacerbation of inflammatory bowel diseases associated with the use of non-steroidal anti-inflammatory drugs: myth or reality? Eur J Clin Pharmacol. 2009;65:963–70.CrossRef
  31.Barrios JM, Litchinberger LM. Role of Biliary phosphatidyl choline in bile acid protection and NSAID injury of the ileal mucosa in rats. Gastroenterology. 2000;118:1179–86.CrossRef PubMed
  32.Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID induced gastrointestinal injury. Nat Med. 1995;1:154–8.CrossRef PubMed
  33.Somasundaram S, Rafi S, Hayllar J, Sigthorsson G, Jacob M, Price AB, et al. Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine. Gut. 1997;41:344–53.PubMedCentral CrossRef PubMed
  34.Petruzzelli M, Vacca M, Moschetta A, Cinzia SR, Palasciano G, van Erpecum KJ, et al. Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: Role of bile salts. Clin Biochem. 2007;40:503–10.CrossRef PubMed
  35.Kelly D, Anthony A, Piasecki C, Lewin J, Pounder RE, Wakefield AJ. Endothelial changes precede mucosal ulceration induced by indomethacin: an experimental study in the rat. Aliment Pharmacol Therapeut. 2000;14:489–96.CrossRef
  36.Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on the gastrointestinal tract. Exp Toxicol Pathol. 2006;58:163–73.CrossRef PubMed
  37.Yamada T, Hoshino M, Hayakawa T, Kamiya Y, Ohhara H, Mizuno K, et al. Bile secretion in rats with indomethacin-induced intestinal inflammation. Am J Physiol. 1996;270:G804–12.PubMed
  38.Conner EM, Brand SJ, Davis JM, Kang DY, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflamm Bowel Dis. 1996;2:133–47.PubMed
  39.Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven; 1992. p. 541–88.
  40.Buffinton GD, Doe WF. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Radic Biol Med. 1995a;22:131-43.
  41.Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Investig. 1998;101:1163–74.PubMedCentral CrossRef PubMed
  42.Borniquel S, Jansson EA, Cole MP, Freeman BA, Lundberg JO. Nitrated oleic acid up-regulates PPARγ and attenuates experimental inflammatory bowel disease. Free Radic Biol Med. 2010;48:499–505.PubMedCentral CrossRef PubMed
  43.Ro JY, Lee B, Kim JY, Chung Y, Chung MH, Lee SK. Inhibitory mechanism of aloe single component (Alprogen) on mediator release in guinea pig lung mast cells activated with specific antigen-antibody reactions. J Pharmacol Exp Therapeut. 2000;292:114–21.
  44.Surjushe A, Vasani R, Saple DG. Aloe Vera: a short review. Indian J Dermatol. 2008;53:163–66.PubMedCentral CrossRef PubMed
  45.Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al. Stereochemical assignment, anti-inflammatory properties and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005;201:713–22.PubMedCentral CrossRef PubMed
  
• 作者单位：Bhaskar Vemu (1)
  S. Selvasubramanian (1)
  V. Pandiyan (2)
  
  1. Department of Veterinary Pharmacology and Toxicology, Madras Veterinary College, Chennai, Tamil Nadu, 600 007, India
  2. Department of Veterinary Physiology and Biochemistry, Madras Veterinary College, Chennai, Tamil Nadu, 600 007, India
  
• 刊物主题：Complementary & Alternative Medicine; Internal Medicine; Chiropractic Medicine;
• 出版者：BioMed Central
• ISSN：1472-6882

文摘

Background Emu oil is a product of animal origin used for the treatment of inflammation, burns etc. as a part of aboriginal medicine in Australia. Crohn’s disease is a common inflammatory manifestation in humans and other animal species relating to the ulceration and digestive disturbances in upper gastro-intestinal tract. Aloe vera is commonly used substance from plant sources for inflammation, wound healing and various other properties. Given the difference in the source of the substances all the while playing a similar therapeutic role in different parts of the world, the present investigation was undertaken to evaluate the protective effect of aloe vera and emu oil alone and in combination; in comparison to sulfasalazine (Allopathic drug) as an alternative for the treatment of Crohn’s disease.